Amanote Research
Register
Sign In
Angiotensin Converting Enzyme Inhibitors and Diabetic Nephropathy.
BMJ
doi 10.1136/bmj.304.6823.327
Full Text
Open PDF
Abstract
Available in
full text
Date
February 8, 1992
Authors
C. E. Mogensen
Publisher
BMJ
Related search
Characterization of Renal Angiotensin-Converting Enzyme 2 in Diabetic Nephropathy
Hypertension
Internal Medicine
Angiotensin-I Converting Enzyme Polymorphism and Diabetic Nephropathy in North India
International Journal of Human Genetics
Genetics
Angiotensin Converting Enzyme (ACE) Inhibitors
Annual Review of Pharmacology and Toxicology
Toxicology
Pharmacology
Dosage of Angiotensin Converting Enzyme Inhibitors
BMJ
Angiotensin-Converting Enzyme Inhibitors Versus Angiotensin Receptor Blockers
JRAAS - Journal of the Renin-Angiotensin-Aldosterone System
Internal Medicine
Endocrinology
Angioedema, Angiotensin Converting Enzyme Inhibitors, and Angiotensin Receptor Blocking Drugs
Canadian Journal of Anaesthesia
Medicine
Anesthesiology
Pain Medicine
Combining Angiotensin-Receptor Blockers With Angiotensin-Converting-Enzyme Inhibitors
CMAJ
Medicine
Angiotensin Converting Enzyme Inhibitors for Cancer Treatment?
Acta Oncologica
Nuclear Medicine
Radiology
Hematology
Oncology
Medicine
Imaging
Addition of Angiotensin Receptor Blockade or Mineralocorticoid Antagonism to Maximal Angiotensin-Converting Enzyme Inhibition in Diabetic Nephropathy
Journal of the American Society of Nephrology : JASN
Medicine
Nephrology